By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Eli Lilly and Company 

Lilly Corporate Center

Indianapolis  Indiana  46285  U.S.A.
Phone: 317-276-2000 Fax: n/a


Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. We have steadfastly remained independent, but not isolated. Across the globe, Lilly has developed productive alliances and partnerships that advance our capacity to develop innovative medicines at lower costs. Lilly is consistently ranked as one of the best companies in the world to work for, and generations of Lilly employees have sustained a culture that values excellence, integrity, and respect for people. Lilly's global employees number approximately 40,000, and our medicines are marketed in 143 countries. Lilly has major research and development facilities in eight countries and conducts clinical trials in more than 50 countries.

Making medicines has never been easy. But in today's global health care environment, the challenges are unprecedented. Familiar ways of working aren't working anymore, so Lilly is transforming to meet the challenges head on — from how we make medicines to how we talk about them. Throughout our organization, we're asking tough questions and discovering better answers.

Around the world people are in need of health care. People with medical needs above and beyond the capabilities of existing medicine. It is here, at the edge of science and medicine that Lilly begins. Lilly has embraced a bold vision. We intend to make a significant contribution to humanity by improving global health in the 21st century. Starting with the work of our scientists, we will place improved outcomes for individual patients at the center of what we do. We will listen carefully to understand patient needs and work with health care partners to provide meaningful benefits for the people who depend on us.

Lilly, a leading innovation driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers through medicines and information for some of the world’s most urgent medical needs.




CEO: John C. Lechleiter, PhD

CFO: Derica W. Rice


Please click here for clinical trial information.

Key Statistics

Ownership: Public

Web Site: Eli Lilly
Employees: 41,500 globally
Symbol: LLY


SLIL Biomedical Corporation  Worldwide licensing agreement with the animal health division for more than 40 compounds that have shown activity in animal infectious diseases.

Emisphere  Osteoporosis; Growth disorders

PanVera LLC 

Medarex, Inc. 


Daiichi Sankyo, Inc. 

Dyax  Antibody phage display

Company News
Boehringer Ingelheim And Eli Lilly (LLY) Release: Glyxambi (Empagliflozin/Linagliptin) Approval Recommended By CHMP For Adults With Type 2 Diabetes In The European Union 9/16/2016 8:14:22 AM
CHMP Recommends Approval Of Eli Lilly (LLY)'s Olaratumab, In Combination With Doxorubicin, For Advanced Soft Tissue Sarcoma 9/16/2016 6:33:20 AM
Levi Garraway, M.D., Ph.D., To Become Senior Vice President Of Global Oncology At Eli Lilly (LLY), Succeeding Richard Gaynor, M.D., Who Is Retiring After A Distinguished Career 9/14/2016 8:06:52 AM
Jamere Jackson Elected To Eli Lilly (LLY) Board Of Directors 8/31/2016 10:43:06 AM
Eli Lilly (LLY) To Participate In Morgan Stanley Global Healthcare Conference 8/24/2016 11:47:31 AM
Why Eli Lilly (LLY) Execs are Bullish About Its Alzheimer's Drug Solanezumab 8/23/2016 6:14:34 AM
Eli Lilly (LLY) And AstraZeneca PLC (AZN) Receive FDA Fast Track Designation For AZD3293, An Investigational Treatment For Early Alzheimer's Disease 8/22/2016 6:54:44 AM
Eli Lilly (LLY)'s Incoming CEO May Carry First Alzheimer's Drug Across The Finish Line 8/22/2016 6:25:17 AM
Eli Lilly (LLY) Announces Joshua Smiley, Anat Ashkenazi Appointed To New Roles, Thomas Grein Retires 8/10/2016 9:50:58 AM
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial 8/10/2016 5:54:38 AM